HBM Partners Mergers & Acquisitions

HBM Partners M&A Summary

In the last 3 years, HBM Partners has invested in 3 companies.

In the last 3 years, HBM Partners has exited 9 companies. The Firm’s most common exit type is ipo (77%). HBM Partners’ largest (disclosed) exit occurred in 2022 when it sold Turning Point Therapeutics for $4.1B.

Sign-up to view HBM Partners’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity103
    • M&A Buy Activity65
    • M&A Sell Activity38
  • M&A Buy/Sell Connections27

HBM Partners

HBM Partners AG

Bundesplatz 1, PO-Box 1145,
Zug, 6300
Switzerland
+41 43 888 7171
www.hbmpartners.com

All (103) Buy (65) Sell (38)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2025-10-15 Aculys Pharma · Life Science
Minato-ku, Japan · www.aculys.com

Aculys Pharma is a biopharmaceutical company focused on the development and commercialization of innovations in the fields of neurology and psychiatry. Aculys Pharma was founded in 2021 and is based in Minato-ku, Japan.

- Add-on Acquisition

Viatris

HBM Partners PE


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.